Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450976) titled 'A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Condition: Biliary Tract Cancer

Intervention: Drug: SHR-A1904 for Injection

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: March 2026

Target Sample Size: 151

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07450976

Publi...